Wells Fargo today maintained an Outperform rating on ViroPharma (NASDAQ: VPHM) with a price target of $35.00 to $37.00. Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE